A recent study conducted by the Israeli medtech startup Nitinotes has revealed that its innovative automated endoscopic suturing system, EndoZip, effectively promotes significant weight loss. This groundbreaking technology allows for endoscopic suturing—placing stitches inside the gastrointestinal tract—without the need for invasive surgery. The procedure reduces the size and capacity of the stomach (gastroplasty), enabling patients to feel satiated after consuming smaller amounts of food, thereby decreasing overall calorie intake.
Nitinotes claims that EndoZip simplifies and accelerates the endoscopic gastroplasty process, making it a more accessible and effective solution for the hundreds of millions of individuals suffering from obesity who may not be candidates for traditional bariatric surgery.
Key Findings
The study indicated that individuals who underwent the EndoZip procedure experienced an average weight loss of 13 percent over a 12-month period. Additionally, the treatment showed improvements in various metabolic health indicators, which are essential for managing obesity-related comorbidities.
According to the company, the results position EndoZip as a promising alternative to existing minimally invasive obesity treatments, thereby broadening the range of options for patients who either do not qualify for or prefer to avoid traditional surgical procedures.
The findings were published in the esteemed journal GIE: Gastrointestinal Endoscopy.
Industry Implications
“The acceptance of our study for publication in GIE validates the potential of EndoZip technology,” said Nitinotes CEO Lloyd Diamond. “This aligns with our mission to enhance accessibility and reduce the invasiveness of obesity treatments.” He emphasized that EndoZip could empower more physicians to integrate this technology into their practices, providing additional options for patients exploring alternatives to conventional medical and surgical interventions.
Related Topic:
What Do Diet Pills Have In Them
